GAD1 and diabetes mellitus: By sequencing the TCR-β repertoire from peripheral blood in children at risk for T1D, we demonstrate that, based upon Vβ gene usage early in life, a subset of children could be identified who later developed distinct islet autoantibody profiles with antibodies directed against GAD and IA-2A followed by clinical diabetes.